{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Testosterone+cypionate+100+mg", "query": { "intervention": "Testosterone cypionate 100 mg" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-10-28T05:39:34.018Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT07898072", "title": "Safety and Efficacy of Weekly Testosterone Cypionate Auto-Injector in Men With Hypogonadism", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Male Hypogonadism" ], "interventions": [ { "name": "Testosterone Cypionate 75 mg", "type": "DRUG" }, { "name": "Testosterone cypionate 50 mg", "type": "DRUG" }, { "name": "Testosterone cypionate 100 mg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Amneal Pharmaceuticals, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "MALE", "summary": "18 Years to 75 Years · Male only" }, "enrollment_count": 190, "start_date": "2026-09-28", "completion_date": "2027-12-31", "has_results": false, "last_update_posted_date": "2026-10-27", "last_synced_at": "2026-10-28T05:39:34.018Z", "location_count": 10, "location_summary": "Santa Monica, California • DeLand, Florida • Miami Lakes, Florida + 7 more", "locations": [ { "city": "Santa Monica", "state": "California" }, { "city": "DeLand", "state": "Florida" }, { "city": "Miami Lakes", "state": "Florida" }, { "city": "Omaha", "state": "Nebraska" }, { "city": "Garden City", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT07898072" }, { "nct_id": "NCT01084759", "title": "A Pilot Study of Parenteral Testosterone and Oral Etoposide as Therapy for Men With Castration Resistant Prostate Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Prostate Cancer" ], "interventions": [ { "name": "Testosterone injection", "type": "DRUG" }, { "name": "Etoposide", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "MALE", "summary": "18 Years and older · Male only" }, "enrollment_count": 16, "start_date": "2010-03", "completion_date": "2014-10", "has_results": true, "last_update_posted_date": "2016-05-09", "last_synced_at": "2026-10-28T05:39:34.018Z", "location_count": 1, "location_summary": "Baltimore, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT01084759" }, { "nct_id": "NCT02090114", "title": "RE-sensitizing With Supraphysiologic Testosterone to Overcome REsistance (The RESTORE Study)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Prostate Cancer" ], "interventions": [ { "name": "Testosterone cypionate", "type": "DRUG" }, { "name": "Testosterone Enanthate", "type": "DRUG" }, { "name": "Abiraterone acetate", "type": "DRUG" }, { "name": "Enzalutamide", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "MALE", "summary": "18 Years and older · Male only" }, "enrollment_count": 112, "start_date": "2014-08-25", "completion_date": "2021-11-11", "has_results": true, "last_update_posted_date": "2022-06-27", "last_synced_at": "2026-10-28T05:39:34.018Z", "location_count": 2, "location_summary": "Washington D.C., District of Columbia • Baltimore, Maryland", "locations": [ { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT02090114" }, { "nct_id": "NCT02286921", "title": "Testosterone Revival Abolishes Negative Symptoms, Fosters Objective Response and Modulates Enzalutamide Resistance", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Castration Resistant Metastatic Prostate Cancer" ], "interventions": [ { "name": "Testosterone cypionate", "type": "DRUG" }, { "name": "Enzalutamide", "type": "DRUG" }, { "name": "Testosterone Enanthate", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "MALE", "summary": "18 Years to 80 Years · Male only" }, "enrollment_count": 222, "start_date": "2015-01", "completion_date": "2020-02-21", "has_results": true, "last_update_posted_date": "2020-11-06", "last_synced_at": "2026-10-28T05:39:34.018Z", "location_count": 17, "location_summary": "Birmingham, Alabama • Duarte, California • Aurora, Colorado + 13 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Duarte", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT02286921" }, { "nct_id": "NCT03716739", "title": "Improving Quality of Life of Prostate Cancer Survivors With Androgen Deficiency", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Prostate Cancer" ], "interventions": [ { "name": "Testosterone Cypionate 100 MG/ML", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Dana-Farber Cancer Institute", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "MALE", "summary": "40 Years and older · Male only" }, "enrollment_count": 136, "start_date": "2019-03-19", "completion_date": "2025-07-16", "has_results": true, "last_update_posted_date": "2026-07-16", "last_synced_at": "2026-10-28T05:39:34.018Z", "location_count": 3, "location_summary": "Baltimore, Maryland • Boston, Massachusetts", "locations": [ { "city": "Baltimore", "state": "Maryland" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT03716739" }, { "nct_id": "NCT03554317", "title": "COMbination of Bipolar Androgen Therapy and Nivolumab", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Castration-resistant Prostate Cancer", "Metastatic Prostate Cancer", "Prostate Cancer" ], "interventions": [ { "name": "Testosterone cypionate", "type": "DRUG" }, { "name": "Nivolumab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "MALE", "summary": "18 Years and older · Male only" }, "enrollment_count": 45, "start_date": "2018-09-05", "completion_date": "2023-01-06", "has_results": true, "last_update_posted_date": "2024-02-20", "last_synced_at": "2026-10-28T05:39:34.018Z", "location_count": 3, "location_summary": "San Francisco, California • Baltimore, Maryland • Boston, Massachusetts", "locations": [ { "city": "San Francisco", "state": "California" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT03554317" }, { "nct_id": "NCT01750398", "title": "Bipolar Androgen-based Therapy for Prostate Cancer (BAT)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Recurrent Prostate Cancer" ], "interventions": [ { "name": "Testosterone cypionate", "type": "DRUG" }, { "name": "Goserelin", "type": "DRUG" }, { "name": "Leuprolide", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "MALE", "summary": "18 Years and older · Male only" }, "enrollment_count": 33, "start_date": "2013-01", "completion_date": "2015-06", "has_results": true, "last_update_posted_date": "2016-12-05", "last_synced_at": "2026-10-28T05:39:34.018Z", "location_count": 1, "location_summary": "Baltimore, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT01750398" }, { "nct_id": "NCT02803073", "title": "Effect of Testosterone Replacement on Exercise Capacity in Hypogonadal Men After a Recent Myocardial Infarction", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Hypogonadism", "Acute Myocardial Infarction: Rehabilitation Phase" ], "interventions": [ { "name": "Testosterone", "type": "DRUG" }, { "name": "Normal Saline", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Texas Tech University Health Sciences Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "MALE", "summary": "18 Years and older · Male only" }, "enrollment_count": 0, "start_date": "2016-08", "completion_date": "2017-05", "has_results": false, "last_update_posted_date": "2019-11-21", "last_synced_at": "2026-10-28T05:39:34.018Z", "location_count": 1, "location_summary": "Odessa, Texas", "locations": [ { "city": "Odessa", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT02803073" }, { "nct_id": "NCT04460872", "title": "Locomotor Training With Testosterone to Promote Bone and Muscle Health After Spinal Cord Injury", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Spinal Cord Injury", "Spinal Cord Injuries", "Trauma, Nervous System", "Wounds and Injury", "Central Nervous System Diseases", "Spinal Cord Diseases", "Gonadal Disorders", "Endocrine System Diseases", "Hypogonadism", "Genital Diseases, Male", "Spinal Cord Trauma", "Injuries, Spinal Cord", "Walking, Difficulty", "Gait Disorders, Neurologic", "Locomotion Disorder, Neurologic", "Wounds and Injuries", "Nervous System Diseases", "Testosterone Deficiency", "Androgen Deficiency", "Hormone Deficiency" ], "interventions": [ { "name": "Testosterone Enanthate", "type": "DRUG" }, { "name": "Locomotor Training", "type": "BEHAVIORAL" } ], "intervention_types": [ "DRUG", "BEHAVIORAL" ], "sponsor": "North Florida Foundation for Research and Education", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "MALE", "summary": "18 Years and older · Male only" }, "enrollment_count": 21, "start_date": "2021-01-31", "completion_date": "2026-06-30", "has_results": false, "last_update_posted_date": "2025-05-06", "last_synced_at": "2026-10-28T05:39:34.018Z", "location_count": 2, "location_summary": "Gainesville, Florida • Jacksonville, Florida", "locations": [ { "city": "Gainesville", "state": "Florida" }, { "city": "Jacksonville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT04460872" }, { "nct_id": "NCT04363164", "title": "Sequential Testosterone and Enzalutamide Prevents Unfavorable Progression", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Castration Resistant Metastatic Prostate Cancer" ], "interventions": [ { "name": "Testosterone cypionate", "type": "DRUG" }, { "name": "Enzalutamide", "type": "DRUG" }, { "name": "Testosterone enanthate", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "90 Years", "sex": "MALE", "summary": "18 Years to 90 Years · Male only" }, "enrollment_count": 150, "start_date": "2020-08-19", "completion_date": "2028-07", "has_results": false, "last_update_posted_date": "2026-07-17", "last_synced_at": "2026-10-28T05:39:34.018Z", "location_count": 6, "location_summary": "San Diego, California • Baltimore, Maryland • Boston, Massachusetts + 3 more", "locations": [ { "city": "San Diego", "state": "California" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Minneapolis", "state": "Minnesota" }, { "city": "Omaha", "state": "Nebraska" } ], "official_url": "https://clinicaltrials.gov/study/NCT04363164" } ] }